Trials / Active Not Recruiting
Active Not RecruitingNCT01878669
Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention
Effects of N-acetyl Cysteine on Periprocedural Myocardial Infarction and Major Cardiac and Cerebral Events in Patients Undergoing Percutaneous Coronary Intervention
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 390 (estimated)
- Sponsor
- Suleyman Demirel University · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the effects of N-acetyl cysteine on periprocedural myocardial infarction and major cardiac and cerebral events in patients undergoing percutaneous coronary intervention and who have moderate to high risk for contrast induced nephropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N-acetyl cysteine | |
| DRUG | Saline |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2017-09-01
- Completion
- 2026-12-01
- First posted
- 2013-06-17
- Last updated
- 2025-05-20
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01878669. Inclusion in this directory is not an endorsement.